JENNY CASCIO: Open Payments
NPI 1578727798 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 27 payments from 12 companies in 2025. Trend: 2023 $754 · 2024 $379 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $106 |
| Neurocrine BioSciences, Inc. | 4 | $102 |
| Teva Pharmaceuticals USA, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Bausch Health US, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Alkermes, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $24 |
Products named: REXULTI, INGREZZA, CAPLYTA, FANAPT, AUSTEDO XR, UZEDY, VRAYLAR, Jornay PM.
Industry payments across NY — which companies pay providers there.
